Theodore L. Harris - Feb 21, 2024 Form 4 Insider Report for BALCHEM CORP (BCPC)

Signature
/s/ Travis Larsen, Attorney in Fact for Theodore L. Harris
Stock symbol
BCPC
Transactions as of
Feb 21, 2024
Transactions value $
-$7,827,660
Form type
4
Date filed
2/23/2024, 04:37 PM
Previous filing
Feb 13, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCPC Common Stock Sale -$1.65M -10.8K -11.24% $152.97 85.3K Feb 21, 2024 Direct F1
transaction BCPC Common Stock Sale -$2.46M -16K -18.78% $153.75 69.3K Feb 21, 2024 Direct F2
transaction BCPC Common Stock Sale -$413K -2.67K -3.85% $154.84 66.6K Feb 21, 2024 Direct F3
transaction BCPC Common Stock Sale -$31.2K -200 -0.3% $155.91 66.4K Feb 21, 2024 Direct
transaction BCPC Common Stock Options Exercise $549K +10K +15.06% $54.87 76.4K Feb 22, 2024 Direct F4
transaction BCPC Common Stock Options Exercise $1.48M +24.4K +31.87% $60.85 101K Feb 22, 2024 Direct F4
transaction BCPC Common Stock Sale -$2.23M -14.5K -14.39% $153.56 86.3K Feb 22, 2024 Direct F5
transaction BCPC Common Stock Sale -$2.16M -14K -16.22% $154.66 72.3K Feb 22, 2024 Direct F6
transaction BCPC Common Stock Sale -$910K -5.86K -8.11% $155.25 66.4K Feb 22, 2024 Direct F7

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BCPC Stock Options (right to buy) Options Exercise $0 +10K $0.00* 0 Feb 22, 2024 Common Stock 10K $54.87 Direct F8
transaction BCPC Stock Options (right to buy) Options Exercise $0 +24.4K $0.00* 0 Feb 22, 2024 Common Stock 24.4K $60.85 Direct F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiples sales ranging from $152.3350 to $153.3200 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.
F2 This transaction was executed in multiples sales ranging from $153.3400 to $154.2900 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.
F3 This transaction was executed in multiples sales ranging from $154.4700 to $155.3800 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.
F4 Exercise of fully vested non-qualified stock options.
F5 This transaction was executed in multiple sales ranging from $153.0800 to $154.0775 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.
F6 This transaction was executed in multiple sales ranging from $154.0800 to $155.0750 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.
F7 This transaction was executed in multiple sales ranging from $155.0800 to $155.5700 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.
F8 Stock options that vested 20% on April 28, 2016, 40% on April 28, 2017, and 40% on April 28, 2018, and are exercisable.
F9 Stock options that vested 20% on February 23, 2017, 40% on February 23, 2018, and 40% on February 23, 2019, and are exercisable.